[FG] Tarr Philip

Berton, Mattia et al. (2024) ‘Antiretroviral Drug Exposure and Response in Obese and Morbidly Obese People With Human Immunodeficiency Virus (HIV): A Study Combining Modelling and Swiss HIV Cohort Data’, Clinical Infectious Diseases, 78, pp. 98–110. Available at: https://doi.org/10.1093/cid/ciad495.

Lüthi-Corridori, Giorgia et al. (2024) ‘Diagnosis and Therapy of Community-Acquired Pneumonia in the Emergency Department: A Retrospective Observational Study and Medical Audit’, Journal of Clinical Medicine, 13. Available at: https://doi.org/10.3390/jcm13020574.

Riebensahm, Carlotta et al. (2024) ‘Brief Report: Decreased Physical Activity and Prolonged Sitting Time Are Associated with Liver Steatosis in People with HIV’, Journal of Acquired Immune Deficiency Syndromes, 95, pp. 179–184. Available at: https://doi.org/10.1097/qai.0000000000003328.

Picker, Julia et al. (2023) ‘Folie à deux - Thrombose und Infektionen’, Praxis. 07.06.2023, 112(7-8), pp. 419–425. Available at: https://doi.org/10.1024/1661-8157/a004004.

Avery Emma F et al. (2023) ‘Leukocyte Count and Coronary Artery Disease Events in People with Human Immunodeficiency Virus: A Longitudinal Study’, Clinical Infectious Diseases, 76, pp. 1969–1979. Available at: https://doi.org/10.1093/cid/ciad033.

Hachfeld Anna et al. (2023) ‘Brief Report: Does Menopause Transition Influence Viral Suppression and Adherence in Women Living With HIV?’, Journal of Acquired Immune Deficiency Syndromes, 92, pp. 399–404. Available at: https://doi.org/10.1097/qai.0000000000003158.

Hovaguimian, F. et al. (2023) ‘Incidence of sexually transmitted infections and association with behavioural factors: Time-to-event analysis of a large pre-exposure prophylaxis (PrEP) cohort’, HIV Medicine, null. Available at: https://doi.org/10.1111/hiv.13543.

Schoepf, Isabella C et al. (2023) ‘Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years’, The Lancet Healthy Longevity, 4, pp. e211–e218. Available at: https://doi.org/10.1016/s2666-7568(23)00037-5.

Schoepf Isabella C. et al. (2023) ‘Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons With Human Immunodeficiency Virus (HIV): The Swiss HIV Cohort Study’, Clinical Infectious Diseases, 76, pp. 48–56. Available at: https://doi.org/10.1093/cid/ciac758.

Schwenke, Johannes M et al. (2023) ‘Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study’, Journal of Infectious Diseases, 228, pp. 742–750. Available at: https://doi.org/10.1093/infdis/jiad179.

Surial Bernard et al. (2023) ‘Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy’, Clinical Infectious Diseases, 77(5), pp. 729–737. Available at: https://doi.org/10.1093/cid/ciad286.

Zimmermann, C. et al. (2023) ‘Pharmacists” approaches to vaccination consultations in Switzerland: A qualitative study comparing the roles of complementary and alternative medicine (CAM) and biomedicine’, BMJ Open, 13. Available at: https://doi.org/10.1136/bmjopen-2023-074883.

Herderschee, J. et al. (2022) ‘High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus’, Clinical Microbiology and Infection, 28(4), p. 611.e1–611.e7. Available at: https://doi.org/10.1016/j.cmi.2021.08.018.

Scherrer AU et al. (2022) ‘Cohort Profile Update: The Swiss HIV Cohort Study (SHCS).’, International journal of epidemiology, 51(1), pp. 33–34j. Available at: https://doi.org/10.1093/ije/dyab141.

Hovaguimian F et al. (2022) ‘Participation, retention and uptake in a multicentre pre-exposure prophylaxis cohort using online, smartphone-compatible data collection.’, HIV medicine, 23(2), pp. 146–158. Available at: https://doi.org/10.1111/hiv.13175.

Deml, M. J. et al. (2022) ‘Trust, affect, and choice in parents” vaccination decision-making and health-care provider selection in Switzerland’, Sociol Health Illn, 44(1), pp. 41–58. Available at: https://doi.org/10.1111/1467-9566.13388.

Grosso, Tomás M. et al. (2022) ‘HIV and aging, biological mechanisms, and therapies: What do we know?’, AIDS Reviews, 24, pp. 79–86. Available at: https://doi.org/10.24875/aidsrev.21000085.

Hachfeld A. et al. (2022) ‘Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS)’, HIV Medicine, 23, pp. 417–425. Available at: https://doi.org/10.1111/hiv.13255.

Jakeman, Bernadette et al. (2022) ‘Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus’, Open Forum Infectious Diseases, 9. Available at: https://doi.org/10.1093/ofid/ofac457.

Riebensahm, C. et al. (2022) ‘Factors Associated With Liver Steatosis in People With Human Immunodeficiency Virus on Contemporary Antiretroviral Therapy’, Open Forum Infectious Diseases, 9. Available at: https://doi.org/10.1093/ofid/ofac538.

Schoepf, Isabella C. et al. (2022) ‘Telomere Length Declines in Persons With Human Immunodeficiency Virus Before Antiretroviral Therapy Start but Not After Viral Suppression: A Longitudinal Study Over >17 Years’, Journal of Infectious Diseases, 225, pp. 1581–1591. Available at: https://doi.org/10.1093/infdis/jiab603.

Tepekule Burcu et al. (2022) ‘Impact of Latent Tuberculosis on Diabetes’, Journal of Infectious Diseases, 225, pp. 2229–2234. Available at: https://doi.org/10.1093/infdis/jiac054.

Damas J et al. (2021) ‘Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV.’, AIDS (London, England), 35(15), pp. 2469–2480. Available at: https://doi.org/10.1097/qad.0000000000003057.

Raffenberg M et al. (2021) ‘Impact of Delaying Antiretroviral Treatment During Primary Human Immunodeficiency Virus Infection on Telomere Length.’, The Journal of infectious diseases, 224(10), pp. 1775–1784. Available at: https://doi.org/10.1093/infdis/jiab186.

Schoepf IC et al. (2021) ‘Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study.’, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(9), pp. 1597–1604. Available at: https://doi.org/10.1093/cid/ciab521.

Engel T et al. (2021) ‘Telomere Length, Traditional Risk Factors, Factors Related to Human Immunodeficiency Virus (HIV) and Coronary Artery Disease Events in Swiss Persons Living With HIV.’, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(7), pp. e2070–e2076. Available at: https://doi.org/10.1093/cid/ciaa1034.

Darling KEA et al. (2021) ‘Alcohol consumption and neurocognitive deficits in people with well-treated HIV in Switzerland’, PLoS ONE, 16(3 March). Available at: https://doi.org/10.1371/journal.pone.0246579.

Chappell, E. et al. (2021) ‘Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) study group’, AIDS, 35(12), pp. 1973–1985. Available at: https://doi.org/10.1097/qad.0000000000002965.

Dietrich, Léna G et al. (2021) ‘Rapid Progression of Kidney Dysfunction in People Living with HIV: Use of Polygenic and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Risk Scores’, Journal of Infectious Diseases, 223, pp. 2145–2153. Available at: https://doi.org/10.1093/infdis/jiaa695.

Jusufoska, Meliha et al. (2021) ‘‘vaccination needs to be easy for the people, right ?’: A qualitative study of the roles of physicians and pharmacists regarding vaccination in Switzerland’, BMJ Open, 11. Available at: https://doi.org/10.1136/bmjopen-2021-053163.

Kovari H. et al. (2021) ‘Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort Study’, HIV Medicine, 22, pp. 623–628. Available at: https://doi.org/10.1111/hiv.13106.

Olarewaju, V. O. et al. (2021) ‘The Youth Attitudes about Vaccines (YAV-5) scale: adapting the parent attitudes about childhood vaccines short scale for use with youth in German, French, and Italian in Switzerland, exploratory factor analysis and mokken scaling analysis’, Hum Vaccin Immunother, 17(12), pp. 5183–5190. Available at: https://doi.org/10.1080/21645515.2021.1980314.

Santos, Galia et al. (2021) ‘The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in Switzerland’, International Journal of STD and AIDS, 32, pp. 729–739. Available at: https://doi.org/10.1177/0956462420987434.

Surial, Bernard et al. (2021) ‘Weight and metabolic changes after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in people living with HIV: A Cohort Study’, Annals of Internal Medicine, 174, pp. 758–767. Available at: https://doi.org/10.7326/m20-4853.

Bick, A.G. et al. (2020) Increased CHIP Prevalence Amongst People Living with HIV. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2020.11.06.20225607.

Tarr PE et al. (2020) ‘Longitudinal Progression of Subclinical Coronary Atherosclerosis in Swiss HIV-Positive Compared With HIV-Negative Persons Undergoing Coronary Calcium Score Scan and CT Angiography.’, Open forum infectious diseases, 7(10), p. ofaa438. Available at: https://doi.org/10.1093/ofid/ofaa438.

Kusejko K et al. (2020) ‘Self-reported Neurocognitive Impairment in People Living With Human Immunodeficiency Virus (HIV): Characterizing Clusters of Patients With Similar Changes in Self-reported Neurocognitive Impairment, 2013-2017, in the Swiss HIV Cohort Study.’, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71(3), pp. 637–644. Available at: https://doi.org/10.1093/cid/ciz868.

Tramèr L et al. (2020) ‘Intra-Abdominal Nocardiosis-Case Report and Review of the Literature.’, Journal of clinical medicine, 9(7). Available at: https://doi.org/10.3390/jcm9072141.

Metral, M. et al. (2020) ‘How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?’, HIV Medicine, 21(5), pp. 342–348. Available at: https://doi.org/10.1111/hiv.12828.

Dietrich LG et al. (2020) ‘Contribution of genetic background and data collection on adverse events of anti-human immunodeficiency virus (HIV) drugs (D:A:D) clinical risk score to chronic kidney disease in swiss HIV-infected persons with normal baseline estimated glomerular filtration rate’, Clinical Infectious Diseases, 70(5), pp. 890–897. Available at: https://doi.org/10.1093/cid/ciz280.

Kovari H. et al. (2020) ‘Antiretroviral drugs associated with subclinical coronary artery disease in the Swiss Human Immunodeficiency Virus Cohort study’, Clinical Infectious Diseases, 70(5), pp. 884–889. Available at: https://doi.org/10.1093/cid/ciz283.

Najjar I et al. (2020) ‘Recurrent Campylobacter Enteritis in Patients with Hypogammaglobulinemia: Review of the Literature.’, Journal of clinical medicine, 9(2). Available at: https://doi.org/10.3390/jcm9020553.

Barcelo C. et al. (2020) ‘Impact of genetic and nongenetic factors on body mass index and waist-hip ratio change in HIV-infected individuals initiating antiretroviral therapy’, Open Forum Infectious Diseases, 7(1). Available at: https://doi.org/10.1093/ofid/ofz464.

Deml, Michael J. et al. (2020) ‘“Problem patients and physicians” failures”: What it means for doctors to counsel vaccine hesitant patients in Switzerland’, Social Science & Medicine, 255, p. 112946. Available at: https://doi.org/10.1016/j.socscimed.2020.112946.

Deml, Michael J. et al. (2020) ‘Collaborating with Complementary and Alternative Medicine (CAM) providers when writing HPV vaccine review articles’, Journal of Clinical Medicine, 9(2), p. 592. Available at: https://doi.org/10.3390/jcm9020592.

Livio, Françoise et al. (2020) ‘Analysis of inappropriate prescribing in elderly patients of the Swiss HIV Cohort Study reveals gender inequity’, The journal of antimicrobial chemotherapy, p. dkaa505. Available at: https://doi.org/10.1093/jac/dkaa505.

Métral, M. et al. (2020) ‘The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile’, HIV Medicine, 21(1), pp. 30–42. Available at: https://doi.org/10.1111/hiv.12795.

Surial, Bernard et al. (2020) ‘Changes in renal function after switching from TDF to TAF in HIV-infected individuals: A prospective cohort study’, Journal of Infectious Diseases, 222, pp. 637–645. Available at: https://doi.org/10.1093/infdis/jiaa125.

Thorball, C.W. et al. (2019) Host genomics of the HIV-1 reservoir size and its decay rate during suppressive antiretroviral treatment. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/19013763.

Schoepf IC et al. (2019) ‘Subclinical Atherosclerosis Imaging in People Living with HIV.’, Journal of clinical medicine, 8(8). Available at: https://doi.org/10.3390/jcm8081125.

Hachfeld, A. et al. (2019) ‘Why do sub-Saharan Africans present late for HIV care in Switzerland?’, HIV Medicine, 20(6), pp. 418–423. Available at: https://doi.org/10.1111/hiv.12727.

Santos GMA et al. (2019) ‘Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland.’, Open forum infectious diseases, 6(7), p. ofz277. Available at: https://doi.org/10.1093/ofid/ofz277.

Rodger, A.J. et al. (2019) ‘Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study’, The Lancet, 393(10189), pp. 2428–2438. Available at: https://doi.org/10.1016/s0140-6736(19)30418-0.

Courlet, Perrine et al. (2019) ‘Polypharmacy, drug–drug interactions, and inappropriate drugs: New challenges in the aging population with HIV’, Open Forum Infectious Diseases, 6. Available at: https://doi.org/10.1093/ofid/ofz531.

Deml, Michael J. et al. (2019) ‘Determinants of vaccine hesitancy in Switzerland: study protocol of a mixed-methods national research programme’, BMJ Open, 9(11), p. e032218. Available at: https://doi.org/10.1136/bmjopen-2019-032218.

Deml, Michael J. et al. (2019) ‘‘We treat humans, not herds!’ : a qualitative study of complementary and alternative medicine (CAM) providers” individualized approaches to vaccination in Switzerland’, Social Science & Medicine, 240, p. 112556. Available at: https://doi.org/10.1016/j.socscimed.2019.112556.

Diaco ND et al. (2019) ‘Psoas abscess due to mycobacterium avium in a patient with chronic lymphocytic leukemia－case report and review’, Journal of Clinical Medicine, 8(2). Available at: https://doi.org/10.3390/jcm8020216.

Tarr, Philip E., Deml, Michael J. and Huber, Benedikt M. (2019) ‘Measles in Switzerland - progress made, but communication challenges lie ahead’, Swiss medical weekly, 149, p. w20105. Available at: https://doi.org/10.4414/smw.2019.20105.

Young J et al. (2019) ‘The comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study.’, Antiviral therapy, 24(5), pp. 343–353. Available at: https://doi.org/10.3851/imp3310.

Diaco ND et al. (2018) ‘Systematic De-escalation of Successful Triple Antiretroviral Therapy to Dual Therapy with Dolutegravir plus Emtricitabine or Lamivudine in Swiss HIV-positive Persons.’, EClinicalMedicine, 6, pp. 21–25. Available at: https://doi.org/10.1016/j.eclinm.2018.11.005.

Bibert S et al. (2018) ‘Interferon lambda 3/4 polymorphisms are associated with AIDS-related Kaposi’s sarcoma.’, AIDS (London, England), 32(18), pp. 2759–2765. Available at: https://doi.org/10.1097/qad.0000000000002004.

Tarr PE and Calmy A (2018) ‘Anti-inflammatory therapy in well controlled HIV infection.’, 5(10). Available at: https://doi.org/10.1016/s2352-3018(18)30250-9.

Tarr PE et al. (2018) ‘Subclinical coronary artery disease in Swiss HIV-positive and HIV-negative persons.’, European heart journal, 39(23), pp. 2147–2154. Available at: https://doi.org/10.1093/eurheartj/ehy163.

Calmy A and Tarr PE (2018) ‘Will NNRTIs be driving forward again?’, 5(5). Available at: https://doi.org/10.1016/s2352-3018(18)30037-7.

Reinschmidt S. et al. (2018) ‘Incidental findings on coronary computed tomography angiography in human immunodeficiency virus (HIV)positive and HIV-negative persons’, Open Forum Infectious Diseases, 5(5). Available at: https://doi.org/10.1093/ofid/ofy084.

Marzel A. et al. (2018) ‘Dietary patterns and physical activity correlate with total cholesterol independently of lipid-lowering drugs and antiretroviral therapy in aging people living with human immunodeficiency virus’, Open Forum Infectious Diseases, 5(4). Available at: https://doi.org/10.1093/ofid/ofy067.

Satta, N. et al. (2018) ‘Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients’, Journal of Infection, 76(2), pp. 186–195. Available at: https://doi.org/10.1016/j.jinf.2017.11.008.

Engel, Tanja et al. (2018) ‘HIV and Aging - Perhaps Not as Dramatic as We Feared?’, Gerontology, 64(5), pp. 446–456. Available at: https://doi.org/10.1159/000489172.

Ruppen, Corinne et al. (2018) ‘Osteoarticular and skin and soft-tissue infections caused by Streptococcus agalactiae in elderly patients are frequently associated with bacteremia’, DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. WOS.SCI, 90, pp. 55–57. Available at: https://doi.org/10.1016/j.diagmicrobio.2017.09.008.

Stolz D et al. (2018) ‘Diagnosis, Prevention and Treatment of Stable COPD and Acute Exacerbations of COPD: The Swiss Recommendations 2018.’, Respiration; international review of thoracic diseases. 23.08.2018, 96(4), pp. 382–398. Available at: https://doi.org/10.1159/000490551.

Torgerson, P.R. et al. (2018) ‘Corrigendum to “Alveolar echinococcosis: From a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years” [J Hepatol 49 (2008) 72–77] (Alveolar echinococcosis: From a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years (2008) 49(1) (72–77), (S0168827808002274) (10.1016/j.jhep.2008.03.023))’, Journal of Hepatology, 69, p. 1208. Available at: https://doi.org/10.1016/j.jhep.2018.08.010.

Bayard C et al. (2017) ‘Associations between antiretroviral treatment and avascular bone necrosis: The swiss HIV cohort study’, Open Forum Infectious Diseases, 4(4). Available at: https://doi.org/10.1093/ofid/ofx177.

Tarr PE and Kovari H (2017) ‘Another statin option in HIV.’, 4(7). Available at: https://doi.org/10.1016/s2352-3018(17)30072-3.

Cecchinato, V. et al. (2017) ‘Impairment of CCR6+ and CXCR3+ Th cell migration in HIV-1 infection is rescued by modulating actin polymerization’, Journal of Immunology, 198(1), pp. 184–195. Available at: https://doi.org/10.4049/jimmunol.1600568.

Turk, Teja et al. (2017) ‘Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis’, eLife, 6, p. e28721. Available at: https://doi.org/10.7554/elife.28721.

Notter G., Amstad G., Drexler B., Loukidis K. (2017) ‘Therapeutic Management in a Patient with Homozygous Sickle Cell Disease and Prior Pulmonary Embolism during the Pregnancy – A Case Report’, J Blood Disord Symptoms Treat , 1(2), pp. 1–3.

Notter,Julia et al. (2017) ‘Sexuell übertragene Infektionen mit Chlamydia trachomatis’, Swiss Medical Forum, 17(34), pp. 705–711. Available at: https://doi.org/10.4414/smf.2017.03020.

Barceló, C. et al. (2016) ‘Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals’, Journal of Antimicrobial Chemotherapy, 71(7), pp. 1933–1942. Available at: https://doi.org/10.1093/jac/dkw050.

Junier T et al. (2016) ‘Contribution of genetic background and clinical risk factors to low-trauma fractures in human immunodeficiency virus (HIV)-positive persons: The Swiss HIV Cohort Study’, Open Forum Infectious Diseases, 3(2). Available at: https://doi.org/10.1093/ofid/ofw101.

Horvath L et al. (2016) ‘Salmonella enterica Subspecies diarizonae Maxillary Sinusitis in a Snake Handler: First Report.’, Open forum infectious diseases, 3(2), p. ofw066. Available at: https://doi.org/10.1093/ofid/ofw066.

Villandre, L. et al. (2016) ‘Assessment of overlap of phylogenetic transmission clusters and communities in simple sexual contact networks: Applications to HIV-1’, PLoS ONE, 11(2). Available at: https://doi.org/10.1371/journal.pone.0148459.

Schweizer M et al. (2016) ‘Chronic Osteomyelitis Due to Tissierella carlieri: First Case.’, Open forum infectious diseases, 3(1), p. ofw012. Available at: https://doi.org/10.1093/ofid/ofw012.

Wirz, Sebastian A. et al. (2016) ‘Pathogen- and antibiotic-specific effects of prednisone in community-acquired pneumonia’, European Respiratory Journal, 48(4), pp. 1150–1159. Available at: https://doi.org/10.1183/13993003.00474-2016.

Notter,J et al. (2016) ‘Coombs-Negative Severe Hemolytic Anemia and Possible Autoimmune Disease in an Adult Following Cytomegalovirus Infection’, 3, p. 00057.

Hachfeld, Anna et al. (2015) ‘Reasons for late presentation to HIV care in Switzerland’, JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. WOS.SSCI, 18. Available at: https://doi.org/10.7448/ias.18.1.20317.

Braun, D.L. et al. (2015) ‘A lead-in with silibinin prior to triple-therapy translates into favorable treatment outcomes in difficult-to-treat HIV/hepatitis C coinfected patients’, PLoS ONE, 10(7). Available at: https://doi.org/10.1371/journal.pone.0133028.

Haas DW and Tarr PE (2015) ‘Perspectives on pharmacogenomics of antiretroviral medications and HIV-associated comorbidities.’, Current opinion in HIV and AIDS, 10(2), pp. 116–22. Available at: https://doi.org/10.1097/coh.0000000000000134.

Blum CA, Nigro N. et al. (2015) ‘Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial’, Lancet, 385(9977), pp. 1511–8. Available at: https://doi.org/10.1016/s0140-6736(14)62447-8.

Guidi,Monia et al. (2015) ‘Vitamin D time profile based on the contribution of non-genetic and genetic factors in HIV-infected individuals of European ancestry.’, Antiviral therapy. 17.07.2014, 20(3), pp. 261–9. Available at: https://doi.org/10.3851/imp2823.

Hasse Barbara et al. (2015) ‘Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population’, Open Forum Infectious Diseases, 2. Available at: https://doi.org/10.1093/ofid/ofv108.

Wandeler G et al. (2015) ‘Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013.’, Open forum infectious diseases, 2(1), p. ofv026. Available at: https://doi.org/10.1093/ofid/ofv026.

Falkowski AL et al. (2014) ‘Pylephlebitis of a variant mesenteric vein complicating sigmoid diverticulitis.’, Journal of radiology case reports, 8(2), pp. 37–45. Available at: https://doi.org/10.3941/jrcr.v8i2.1698.

Blum, C. A. et al. (2014) ‘Corticosteroid treatment for community-acquired pneumonia - the STEP trial: study protocol for a randomized controlled trial’, Trials, 15, p. 257. Available at: https://doi.org/10.1186/1745-6215-15-257.

Sprenger, K. et al. (2014) ‘Sexually transmitted infections in HIV-infected people in Switzerland: Cross-sectional study’, PeerJ, 2014(1). Available at: https://doi.org/10.7717/peerj.537.

Falkowski Anna L. et al. (2013) ‘Isolated pancreatic tuberculosis: A case report and radiological comparison with cystic pancreatic lesions radiological comparison with cystic pancreatic lesions’, Journal of Radiology Case Reports, 7, pp. 1–11. Available at: https://doi.org/10.3941/jrcr.v7i1.1292.

Rotger Margalida et al. (2013) ‘Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons’, Clinical Infectious Diseases, 57, pp. 112–121. Available at: https://doi.org/10.1093/cid/cit196.

Zbinden A et al. (2012) ‘Streptococcus tigurinus sp. nov., isolated from blood of patients with endocarditis, meningitis and spondylodiscitis.’, International journal of systematic and evolutionary microbiology. 21.02.2012, 62(Pt 12), pp. 2941–2945. Available at: https://doi.org/10.1099/ijs.0.038299-0.

Zbinden A et al. (2012) ‘Streptococcus tigurinus, a novel member of the Streptococcus mitis group, causes invasive infections.’, Journal of clinical microbiology. 03.07.2012, 50(9), pp. 2969–73. Available at: https://doi.org/10.1128/jcm.00849-12.

Linke GR et al. (2012) ‘Transvaginal access for NOTES: a cohort study of microbiological colonization and contamination.’, Endoscopy. 23.04.2012, 44(7), pp. 684–9. Available at: https://doi.org/10.1055/s-0032-1309390.

Vrouenraets, S. M. E. et al. (2012) ‘Longer Prior Exposure to Zidovudine/Lamivudine-Containing Combination Antiretroviral Therapy, Age, and Male Gender Are Each Associated With Reduced Subcutaneous Adipose Tissue’, HIV CLINICAL TRIALS. WOS.SCI, 13, pp. 103–110.